Journal of Hematology & Oncology provides a forum for top-quality research in the fields of hematology and oncology. The journal also publishes reviews and research highlights on "hot topics" from leading experts in the field. Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network (CAHON).
《血液学与肿瘤学杂志》为血液学和肿瘤学领域的高质量研究提供了一个论坛。该杂志还发布了该领域领先专家关于 “热门话题” 的评论和研究要点。《血液学与肿瘤学杂志》是美国华裔血液学家和肿瘤学家网络 (CAHON) 的官方杂志。
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0760-3
lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-018-0690-5
Cancer-associated adipocytes: key players in breast cancer progression
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0778-6
Tumor neoantigens: from basic research to clinical applications
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0787-5
miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0708-7
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0724-7
Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0783-9
Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0699-4
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0701-1
Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-018-0689-y
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0746-1
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0786-6
DLL3: an emerging target in small cell lung cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0745-2
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-018-0686-1
LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0773-y
Emerging agents and regimens for hepatocellular carcinoma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0794-6
Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0782-x
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0732-7
Chimeric antigen receptor T cell therapies for multiple myeloma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0823-5
Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0730-9
Targeting CLL-1 for acute myeloid leukemia therapy
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0726-5
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0790-x
Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0703-z
Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0739-0
Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0799-1
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0762-1
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0707-8
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0800-z
Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0753-2
Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0744-3
Emerging therapies for non-small cell lung cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0731-8
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0757-y
Myeloid-derived suppressor cells in hematological malignancies: friends or foes
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0797-3
Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0719-4
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0835-1
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-018-0691-4
Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0822-6
Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0727-4
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0827-1
Novel and emerging therapies for B cell lymphoma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0752-3
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0714-9
Incidence and mortality of multiple myeloma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0807-5
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0769-7
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0751-4
Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0803-9
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0789-3
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0775-9
Correction to: Selective killing of circulating tumor cells prevents metastasis and extends survival
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-018-0688-z
Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0816-4
Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
来源期刊：Journal of Hematology & OncologyDOI：10.1186/s13045-019-0715-8
